Shape Therapeutics to Present Data Highlighting Advances in Its AI-Driven RNA Technology Platforms at the 2022 ASGCT Annual Meeting
12 mai 2022 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics® Inc. the RNA technology company advancing programmable medicine, today announced new data from its RNAfix®, RNAskipTM and AAVidTM...
Shape Therapeutics Welcomes Google and Stripe Veterans Gayathri Rajan, Kelly Sims to its Board of Directors
26 avr. 2022 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, April 26, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc., the RNA technology company advancing programmable medicine, today announced the addition of two new members to its board of...
Shape Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
06 janv. 2022 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company creating the future of RNA technologies, today announced that Francois Vigneault, PhD.,...
Shape Therapeutics Appoints David J. Huss, Ph.D., as Chief Scientific Officer and Lisa Taylor Ash, J.D., as General Counsel
09 nov. 2021 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment...
Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease indications
24 août 2021 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced a multi-target...
Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy
15 juil. 2021 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion...
UPDATE – Shape Therapeutics to Present the Discovery of Muscle-Specific AAVs at the Jefferies 2021 Virtual Healthcare Conference
28 mai 2021 20h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, May 28, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, today announced that...
Shape Therapeutics to Present the Discovery of Muscle-Specific AAVs at the Jefferies 2021 Virtual Healthcare Conference
25 mai 2021 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, May 25, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, today announced that...
Shape Therapeutics Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
04 mai 2021 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, May 04, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, today announced two abstracts...
Shape Therapeutics Welcomes Patrick Bigot as its Chief Business Officer
20 avr. 2021 08h00 HE
|
Shape Therapeutics, Inc.
SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the...